当前位置: X-MOL 学术Lancet Respir. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pneumonia research: time to fill in the gaps.
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2019-10-17 , DOI: 10.1016/s2213-2600(19)30400-x
The Lancet Respiratory Medicine

Pneumonia remains a leading cause of death worldwide without substantial improvements in mortality since the introduction of antibiotics over 50 years ago. Approximately 1 million adults in the USA attend hospital for the treatment of pneumonia each year, and 50 000 die from the disease, with the majority being older than 65 years. Community-acquired pneumonia (CAP) is responsible for most of the health care burden of pneumonia and on Oct 1, 2019, the American Thoracic Society released new guidelines on the diagnosis and treatment of adults with CAP.

中文翻译:

肺炎研究:填补空白的时间。

自从50多年前引入抗生素以来,肺炎仍然是全球范围内主要的死亡原因,但死亡率没有实质性改善。每年在美国大约有100万成年人入院治疗肺炎,其中5万人死于该病,大多数年龄超过65岁。社区获得性肺炎(CAP)承担了肺炎的大部分医疗保健负担,2019年10月1日,美国胸科协会发布了有关成人CAP诊断和治疗的新指南。
更新日期:2019-11-26
down
wechat
bug